Variant report

Variant	esv3347790
Chromosome Location	chr1:212687079-212689577
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:15)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:212663187..212667039-chr1:212686323..212689300,3	K562	blood:
2	chr1:212688702..212690352-chr1:212731451..212733749,2	K562	blood:
3	chr1:212686720..212688652-chr1:212736381..212737960,2	K562	blood:
4	chr1:212687310..212689846-chr1:212695967..212699890,3	K562	blood:
5	chr1:212685969..212688191-chr1:212785458..212787889,2	K562	blood:
6	chr1:212686498..212689410-chr1:212730977..212733279,2	MCF-7	breast:
7	chr1:212685711..212688153-chr1:212791617..212793606,2	K562	blood:
8	chr1:212688645..212690882-chr1:212691410..212694199,2	MCF-7	breast:
9	chr1:212686747..212688926-chr1:212729063..212731425,2	K562	blood:
10	chr1:212683483..212690052-chr1:212778903..212785088,8	K562	blood:
11	chr1:212663791..212666125-chr1:212687800..212689535,2	K562	blood:
12	chr1:212675568..212680156-chr1:212685148..212688870,4	K562	blood:
13	chr1:212687346..212690563-chr1:212787177..212790270,4	K562	blood:
14	chr1:212683483..212692182-chr1:212779770..212786326,12	K562	blood:
15	chr1:212687936..212690352-chr1:212730094..212732951,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM206-4	chr1:212687866-212688157	XLOC_001194
2	lnc-TMEM206-4	chr1:212687891-212688141	NONHSAT009374
3	lnc-TMEM206-4	chr1:212687632-212687654	NONHSAT009374

No data

Variant related genes	Relation type
ENSG00000260805	chromatin interactions
ENSG00000264590	chromatin interactions
ENSG00000162772	chromatin interactions

Extended variants
information (count: 88 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:88 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185632976	chr1:212687089-212687090	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs565496401	chr1:212687137-212687138	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs545733	chr1:212687151-212687152	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs377693991	chr1:212687187-212687188	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs564003627	chr1:212687204-212687205	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs533622030	chr1:212687276-212687277	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs562482072	chr1:212687296-212687297	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs147924819	chr1:212687297-212687298	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs548213545	chr1:212687321-212687322	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs116764497	chr1:212687324-212687325	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs368007209	chr1:212687397-212687398	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs527601726	chr1:212687417-212687418	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs552161176	chr1:212687423-212687424	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs570703855	chr1:212687449-212687450	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs537681123	chr1:212687466-212687467	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs549938722	chr1:212687467-212687468	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs569057608	chr1:212687479-212687480	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs536305812	chr1:212687548-212687549	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs561064529	chr1:212687631-212687632	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs566499766	chr1:212687725-212687726	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs750227	chr1:212687806-212687807	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs750228	chr1:212687808-212687809	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs577453996	chr1:212687857-212687858	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs112545253	chr1:212687881-212687882	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
25	rs371503039	chr1:212687930-212687931	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
26	rs574597975	chr1:212687939-212687940	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
27	rs549412551	chr1:212687974-212687975	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
28	rs77604319	chr1:212687996-212687997	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
29	rs190740714	chr1:212688019-212688020	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
30	rs527317360	chr1:212688048-212688049	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
31	rs79157337	chr1:212688068-212688069	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
32	rs564265374	chr1:212688080-212688081	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
33	rs531632467	chr1:212688094-212688095	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
34	rs576302322	chr1:212688097-212688098	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
35	rs141776638	chr1:212688109-212688110	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
36	rs530155564	chr1:212688110-212688111	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
37	rs902440	chr1:212688128-212688129	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
38	rs566608235	chr1:212688129-212688130	Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
39	rs533977919	chr1:212688212-212688213	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs558904824	chr1:212688314-212688315	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs571057750	chr1:212688379-212688380	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs1110837	chr1:212688387-212688388	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs1110836	chr1:212688405-212688406	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs538494077	chr1:212688462-212688463	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs556814277	chr1:212688488-212688489	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs575060350	chr1:212688547-212688548	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs147078942	chr1:212688578-212688579	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs368016187	chr1:212688579-212688580	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs147404776	chr1:212688584-212688585	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs201925142	chr1:212688585-212688586	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Trisomy 5 syndrome	21098271	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
Multiple myeloma	16461302	CNVD
van der Woude syndrome	22470819	CNVD
van der Woude syndrome	20818247	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	17060936	CNVD
Atypical hemolytic uremic syndrome	19861685	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Medulloblastoma	16783165	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Holoprosencephaly	19184110	CNVD
Breast cancer	21069454	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Mental retardation	19951919	CNVD
Non-syndromic sensorineural hearing loss	17873649	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:294 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:212681000-212688600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr1:212682600-212687400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr1:212685200-212689000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr1:212685400-212688000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr1:212685600-212687600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
6	chr1:212685800-212687600	Bivalent Enhancer	Fetal Muscle Leg	muscle
7	chr1:212686200-212687400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
8	chr1:212686200-212687600	Bivalent Enhancer	NHDF-Ad	bronchial
9	chr1:212686200-212687800	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
10	chr1:212686200-212687800	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
11	chr1:212686200-212687800	Bivalent Enhancer	HSMM	muscle
12	chr1:212686200-212687800	Enhancers	HSMMtube	muscle
13	chr1:212686200-212688200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr1:212686200-212688400	Enhancers	NH-A	brain
15	chr1:212686400-212687400	Flanking Active TSS	Hela-S3	cervix
16	chr1:212686400-212687400	Bivalent Enhancer	HMEC	breast
17	chr1:212686400-212687600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr1:212686400-212687600	Enhancers	Right Ventricle	heart
19	chr1:212686400-212687600	Enhancers	Spleen	Spleen
20	chr1:212686400-212687800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr1:212686400-212687800	Bivalent Enhancer	NHLF	lung
22	chr1:212686400-212688000	Enhancers	Breast Myoepithelial Primary Cells	Breast
23	chr1:212686400-212688000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr1:212686400-212688000	Bivalent Enhancer	Placenta	Placenta
25	chr1:212686400-212688000	Enhancers	Left Ventricle	heart
26	chr1:212686400-212688400	Enhancers	Pancreas	Pancrea
27	chr1:212686600-212687400	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr1:212686600-212687400	Flanking Active TSS	A549	lung
29	chr1:212686600-212687600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr1:212686600-212688000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr1:212686800-212687400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr1:212686800-212687400	Bivalent Enhancer	Adipose Nuclei	Adipose
33	chr1:212686800-212687400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
34	chr1:212686800-212687600	Enhancers	Right Atrium	heart
35	chr1:212686800-212687800	Bivalent Enhancer	Psoas Muscle	Psoas
36	chr1:212687000-212687200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr1:212687000-212687200	Enhancers	Brain Angular Gyrus	brain
38	chr1:212687000-212687400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr1:212687000-212687400	Enhancers	Aorta	Aorta
40	chr1:212687000-212687400	Enhancers	Brain Anterior Caudate	brain
41	chr1:212687000-212687400	Bivalent Enhancer	Brain Germinal Matrix	brain
42	chr1:212687000-212687400	Enhancers	Brain Hippocampus Middle	brain
43	chr1:212687000-212687400	Enhancers	Brain Inferior Temporal Lobe	brain
44	chr1:212687000-212687400	Enhancers	Brain Substantia Nigra	brain
45	chr1:212687000-212687400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
46	chr1:212687000-212687400	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
47	chr1:212687000-212687600	Bivalent Enhancer	Fetal Intestine Large	intestine
48	chr1:212687000-212687600	Bivalent Enhancer	Fetal Stomach	stomach
49	chr1:212687000-212687800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
50	chr1:212687000-212687800	Bivalent Enhancer	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links